146 related articles for article (PubMed ID: 37082500)
1. Gradual and Remarkable Tumor Shrinkage Following Seven-Fraction Stereotactic Radiosurgery Alone With a Marginal Dose of 48.3 Gy for Large Lobar Possibly Intra-sulcal Brain Metastasis From Renal Cell Carcinoma.
Ohtakara K; Aoki S; Tajima M; Ohno T; Suzuki K
Cureus; 2023 Mar; 15(3):e36346. PubMed ID: 37082500
[TBL] [Abstract][Full Text] [Related]
2. Local Control Failure After Five-Fraction Stereotactic Radiosurgery Alone for Symptomatic Brain Metastasis From Squamous Cell Lung Carcinoma Despite 43 Gy to Gross Tumor Margin With Internal Steep Dose Increase and Tumor Shrinkage During Irradiation.
Ohtakara K; Tanahashi K; Kamomae T; Ito E; Suzuki K
Cureus; 2023 May; 15(5):e38645. PubMed ID: 37284398
[TBL] [Abstract][Full Text] [Related]
3. Ten-Fraction Stereotactic Radiosurgery With Different Gross Tumor Doses and Inhomogeneities for Brain Metastasis of >10 cc: Treatment Responses Suggesting Suitable Biological Effective Dose Formula for Single and 10 Fractions.
Ohtakara K; Nakabayashi K; Suzuki K
Cureus; 2023 Feb; 15(2):e34636. PubMed ID: 36895545
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Sustained Complete Remission With Minimal Adverse Effects Following Radiosurgery for 2-cm Brain Metastasis With Deep Eloquent Location From Lung Adenocarcinoma Despite Low Marginal Dose and High 12 Gy Volume.
Ohtakara K; Nakao M; Muramatsu H; Suzuki K
Cureus; 2023 Mar; 15(3):e36680. PubMed ID: 37113354
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Brain Metastasis Shrinking and Deviation During 10-Fraction Stereotactic Radiosurgery With Late Sequela: Suggesting Dose Ramification Between Tumor Eradication and Symptomatic Radionecrosis.
Ohtakara K; Tanahashi K; Kamomae T; Miyata K; Suzuki K
Cureus; 2023 Jan; 15(1):e33411. PubMed ID: 36751179
[TBL] [Abstract][Full Text] [Related]
6. Nineteen-Month Immunity to Adverse Radiation Effects Following 5-Fraction Re-radiosurgery With 43.6 Gy for Local Progression After Prior 3-Fraction Radiosurgery for Brain Metastasis From Pan-Negative Lung Adenocarcinoma.
Ohtakara K; Nakao M; Muramatsu H; Suzuki K
Cureus; 2023 Oct; 15(10):e46374. PubMed ID: 37920648
[TBL] [Abstract][Full Text] [Related]
7. Volumetric-Modulated Arc-Based Re-radiosurgery With Simultaneous Reduced-Dose Whole-Brain Irradiation for Local Failures Following Prior Radiosurgery of Brain Oligometastases From Small Cell Lung Cancer.
Ohtakara K; Arakawa S; Nakao M; Muramatsu H; Suzuki K
Cureus; 2023 Aug; 15(8):e44492. PubMed ID: 37791190
[TBL] [Abstract][Full Text] [Related]
8. Five-Fraction Stereotactic Radiosurgery With Non-Contrast-Enhanced MRI-Based Target Definition and Moderate Dose Spillage Margin for Limited Brain Metastases With Impaired Renal Function.
Ohtakara K; Suzuki K
Cureus; 2023 Apr; 15(4):e37384. PubMed ID: 37182057
[TBL] [Abstract][Full Text] [Related]
9. An Extremely Inhomogeneous Gross Tumor Dose is Suitable for Volumetric Modulated Arc-Based Radiosurgery with a 5-mm Leaf-Width Multileaf Collimator for Single Brain Metastasis.
Ohtakara K; Suzuki K
Cureus; 2023 Feb; 15(2):e35467. PubMed ID: 36999102
[TBL] [Abstract][Full Text] [Related]
10. Fifteen-Fraction Radiosurgery Followed by Reduced-Dose Whole-Brain Irradiation With a Total Biologically Effective Dose of >90-100 Gy for a Locally Invasive Brain Metastasis From Lung Adenocarcinoma With a High Dissemination Potential.
Ohtakara K; Ohka F; Tanahashi K; Yamada T; Suzuki K
Cureus; 2023 Nov; 15(11):e49596. PubMed ID: 38161920
[TBL] [Abstract][Full Text] [Related]
11. 5-Fraction Re-radiosurgery for Progression Following 8-Fraction Radiosurgery of Brain Metastases From Lung Adenocarcinoma: Importance of Gross Tumor Coverage With Biologically Effective Dose ≥80 Gy and Internal Dose Increase.
Ohtakara K; Tanahashi K; Kamomae T; Suzuki K
Cureus; 2023 Jul; 15(7):e42299. PubMed ID: 37609081
[TBL] [Abstract][Full Text] [Related]
12. Five-Fraction Radiosurgery Using a Biologically Equivalent Dose of a Single Fraction of 24 Gy for a 3-cm Parasagittal Para-Central Sulcus Brain Metastasis From Adenocarcinoma of the Cecum.
Ohtakara K; Kondo T; Obata Y; Fujii K; Suzuki K
Cureus; 2023 Nov; 15(11):e48799. PubMed ID: 38098911
[TBL] [Abstract][Full Text] [Related]
13. Modified Dynamic Conformal Arcs With Forward Planning for Radiosurgery of Small Brain Metastasis: Each Double Arc and Different To-and-Fro Leaf Margins to Optimize Dose Gradient Inside and Outside the Gross Tumor Boundary.
Ohtakara K; Suzuki K
Cureus; 2023 Feb; 15(2):e34831. PubMed ID: 36919061
[TBL] [Abstract][Full Text] [Related]
14. Robotic Radiosurgical Boost After Whole-Brain Radiotherapy for 12 Brain Metastases: En Bloc Consecutive Irradiation With Comprehensively Optimized Single Plan for Eight Lesions Totaling 118 cc.
Ohtakara K; Tanahashi K; Yamada T; Tsunoda N; Suzuki K
Cureus; 2023 Dec; 15(12):e51367. PubMed ID: 38292980
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
17. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
18. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
19. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
20. The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.
Yamada T; Ohtakara K; Kamomae T; Itoh J; Shimada H; Ishihara S; Naganawa S
Cureus; 2022 Jun; 14(6):e25888. PubMed ID: 35844334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
